Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$15.9M
3 rounds on record
Latest round
$250k
Venture round · May 2026 · 4 mo ago
Team
16
US Form 5500 (plan participants) · Dec 2025 · -11% in a year
Backers
2
Invest Nebraska, Nebraska Angels
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 21
Raised a round Venture round $250k · SEC Form D
May 2, 2025
Raised a round Venture round $525k · SEC Form D
Nov 3, 2023
Raised a round Venture round $15.1M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2026 | $250k | — | SEC Form D |
| Venture round | May 2025 | $525k | — | SEC Form D |
| Venture round | Nov 2023 | $15.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Centese, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Evan LuxonExecutive Officer, DirectorSEC Form D
Randy PrestonExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Invest Nebraska 
Nebraska Angels Similar startupsby what they do, their industry and backers
Arpelos designs multivalent medicines with transformative outcomes.
A smarter surgical platform. We're building the intelligence layer for surgery, starting with endourology.
Lightweight insulating aggregate that delivers structural performance, insulation, and drainage in a single low carbon material.
Welcome to CCX - digital tools purposely-built for market access. Explore our 4 transformative tools, and industry-leading expertise.
Transformative Vascular & Valve Implants.
ALETHIA AI is a research and development studio building at the intersection of two of the most transformative technologies of our time…
News
New Study Demonstrates Thoraguard Automated Chest Tube System Significantly Improves Recovery After Cardiac Surgery
Statistically significant reductions in postoperative atrial fibrillation, pain scores, and hospital stay highlight innovation in digital chest drainage and enhanced recovery. Omaha, NE - April 27, 2024 - Centese, Inc., a leader in innovation for cardioth
Read more
Report
Centese, Inc. Secures Series B Funding and Strengthens Board With New Director
Centese, Inc., a leader in digital surgery technology, announces the successful closing of its $15M Series B funding round....
Read more
Report
Centese, Inc. Secures Series B Funding and Strengthens Board With New Director
Company secures funding to fuel expansion of its Thoraguard System; adds veteran medtech leader Timothy Still to Board of Directors
Read more
Report
Thoraguard Intelligent Chest Tube Management System Reduces Hospital Stay; Preferred by Healthcare Providers
New Peer-Reviewed Clinical Study Demonstrates Thoraguard Advantages Over Conventional Analog Systems Following Lung Surgery OMAHA, Ne., September 13, 2022-Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoragu
Read more
Report
Study validates the first automated chest tube clearance system for cardiac surgery
Peer-reviewed clinical study shows Thoraguard delivers effective, automated chest tube drainage following cardiac surgery Omaha, NE, July 26, 2022 - Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard digital drainage system f
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Evan Luxon
Executive Officer, Director
Randy Preston
Executive Officer, Director
Alan Chesler
Director
Dan Burnett
Director
Deepak Gangahar
Director
Radu Cautis
Director
Daniel Burnett
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Omaha
United States
HQ
CENTESE, INC. 4156 S 52nd St. Omaha, NE 68117
50-200 est. staff
CENTESE, INC. 4156 S 52nd St., Omaha, NE 68117